• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

帕博利珠单抗相关的颌骨坏死。

Pembrolizumab related osteonecrosis of the jaw.

作者信息

Patel Vinod, Carey Barbara

机构信息

Fl 23, Oral Surgery Dept, Guy's & St Thomas' Hospital, London SE1 9RT, United Kingdom.

Fl 2, Head & Neck Dept, Guy's & St Thomas' Hospital, London SE1 9RT, United Kingdom.

出版信息

Br J Oral Maxillofac Surg. 2023 Dec;61(10):704-706. doi: 10.1016/j.bjoms.2023.08.241. Epub 2023 Oct 12.

DOI:10.1016/j.bjoms.2023.08.241
PMID:37957097
Abstract

Medication related osteonecrosis of the jaw (MRONJ) is a serious complication with potential implications on patients' ongoing medical care. This case report describes a case of MRONJ from pembrolizumab; a novel immune checkpoint inhibitor drug.

摘要

药物相关性颌骨坏死（MRONJ）是一种严重的并发症，可能会对患者的持续医疗护理产生影响。本病例报告描述了一例由帕博利珠单抗引起的MRONJ病例；帕博利珠单抗是一种新型免疫检查点抑制剂药物。

相似文献

1
Pembrolizumab related osteonecrosis of the jaw.帕博利珠单抗相关的颌骨坏死。
Br J Oral Maxillofac Surg. 2023 Dec;61(10):704-706. doi: 10.1016/j.bjoms.2023.08.241. Epub 2023 Oct 12.
2
Interventions for managing medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死的管理干预措施。
Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD012432. doi: 10.1002/14651858.CD012432.pub2.
3
What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.抗吸收药物 (ARDs) 对骨质疏松症患者药物相关性颌骨坏死 (MRONJ) 发展的影响：系统评价。
J Craniomaxillofac Surg. 2017 Sep;45(9):1493-1502. doi: 10.1016/j.jcms.2017.05.028. Epub 2017 Jun 3.
4
Interventions for managing medication-related osteonecrosis of the jaw.干预措施管理与药物相关的颌骨坏死。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD012432. doi: 10.1002/14651858.CD012432.pub3.
5
A systematic review of metastatic cancer presenting in osteonecrosis of the jaws (MC-ONJ) in patients undergoing antiresorptive and/or antiangiogenic therapy for skeletal-related adverse events.抗吸收和/或抗血管生成药物治疗骨骼相关不良事件所致颌骨骨坏死中转移性癌症（MC-ONJ）的系统评价。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2021 Jun;131(6):650-659. doi: 10.1016/j.oooo.2021.01.001. Epub 2021 Jan 8.
6
Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.特立帕肽治疗药物相关性颌骨坏死是否有效？系统评价和荟萃分析。
Osteoporos Int. 2021 Dec;32(12):2449-2459. doi: 10.1007/s00198-021-06078-z. Epub 2021 Jul 31.
7
Antiresorptive drug-related osteonecrosis of the jaw.抗吸收药物相关的颌骨坏死
Dent Clin North Am. 2014 Apr;58(2):369-84. doi: 10.1016/j.cden.2013.12.006.
8
Guselkumab: A new etiological factor of medication related osteonecrosis of the jaw (MRONJ)? A case report.古塞单抗：药物相关性颌骨坏死（MRONJ）的新病因学因素？一例报告。
J Stomatol Oral Maxillofac Surg. 2024 Sep;125(5S1):101985. doi: 10.1016/j.jormas.2024.101985. Epub 2024 Jul 25.
9
Awareness and Attitude Towards MRONJ Among Physicians Prescribing Antiresorptive Drugs: A Cross-Sectional Study.开具抗骨吸收药物的医生对药物相关颌骨坏死的认知与态度：一项横断面研究
BMC Oral Health. 2025 Jul 2;25(1):985. doi: 10.1186/s12903-025-06490-5.
10
The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature.人羊膜（hAM）在药物相关性颌骨坏死（MRONJ）治疗策略中的应用：文献的系统评价和荟萃分析。
Medicina (Kaunas). 2023 May 17;59(5):968. doi: 10.3390/medicina59050968.

引用本文的文献

1
Harnessing the Gut Microbiome in Cancer Immunotherapy: Mechanisms, Challenges, and Routes to Personalized Medicine-A Systematic Review.癌症免疫治疗中肠道微生物群的应用：机制、挑战及个性化医疗途径——一项系统综述
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251365700. doi: 10.1177/15330338251365700. Epub 2025 Aug 28.
2
Introducing equivalent and threshold doses in the assessment of medication-related osteonecrosis of the jaw risk: insights from a descriptive study in Iran.在颌骨药物相关性骨坏死风险评估中引入等效剂量和阈剂量：来自伊朗一项描述性研究的见解
Support Care Cancer. 2025 Jul 6;33(7):661. doi: 10.1007/s00520-025-09649-6.
3
Exploring the Impact of Novel Anti-Cancer Therapies on Jaw Osteonecrosis and Other Bones: A Comprehensive Review.
探索新型抗癌疗法对颌骨坏死及其他骨骼的影响：一项综述
J Clin Med. 2024 Mar 25;13(7):1889. doi: 10.3390/jcm13071889.